BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15541860)

  • 1. Evaluation of causes of increased incidence of cervical cancer in Slovenia.
    Smrkolj S; Rakar S; Mozina A; Erzen M
    Eur J Obstet Gynecol Reprod Biol; 2004 Dec; 117(2):213-21. PubMed ID: 15541860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological characteristics of cervical cancer between 2003 and 2005, after the introduction of a national cancer screening program in Slovenia.
    Takac I; Ursic-Vrscaj M; Repse-Fokter A; Kodric T; Rakar S; Mozina A; Smrkolj S; Primic-Zakelj M; Strzinar V; Vakselj A; Arko D
    Eur J Obstet Gynecol Reprod Biol; 2008 Sep; 140(1):82-9. PubMed ID: 18400358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of negative and low-grade cervical smears in women with invasive cervical cancer after the first 3 years of the national cervical screening programme in Slovenia.
    Repše-Fokter A; Pogačnik A; Snoj V; Primic-Žakelj M; Fležar MS
    Cytopathology; 2012 Feb; 23(1):23-9. PubMed ID: 20964743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. False negative rate in mass screening for cervical cancer.
    Sato S; Mikino H; Matsunaga G; Yajima A
    Acta Cytol; 1998; 42(3):836-7. PubMed ID: 9622728
    [No Abstract]   [Full Text] [Related]  

  • 6. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
    Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
    J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pap smear screening history of women with squamous cell carcinoma and adenocarcinoma of the cervix.
    Pak SC; Martens M; Bekkers R; Crandon AJ; Land R; Nicklin JL; Perrin LC; Obermair A
    Aust N Z J Obstet Gynaecol; 2007 Dec; 47(6):504-7. PubMed ID: 17991118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
    van der Aa MA; Schutter EM; Looijen-Salamon M; Martens JE; Siesling S
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):204-9. PubMed ID: 18093720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri.
    Nieminen P; Kallio M; Hakama M
    Obstet Gynecol; 1995 Jun; 85(6):1017-21. PubMed ID: 7770247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cervical cancer in the young woman].
    Marie G; Barjot P; Crouet H; Mace-Lesech J; Dommesent D; Uzan M
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(7):743-7. PubMed ID: 8308200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and treatment of invasive cervical cancer in Cambodia (apropos of 35 cases)].
    Monchy D; Lieng CR; Kruy LS; Kahler K; Eav S
    Bull Soc Pathol Exot; 2005 Sep; 98(3):183-6. PubMed ID: 16267957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of cervical carcinoma in a high-risk, non-screened area results of a retrospective analysis on the Dutch Caribbean Antilles from 1983 to 1998.
    Bax A; Voigt RR; Coronel CC; Putter H; de Bie Leuving Tjeenk RM; van Marwijk HW
    West Indian Med J; 2004 Jun; 53(3):150-4. PubMed ID: 15352742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cervical cancer in Frederiksborg County 1990-1991].
    Ingeholm P; Glenthøj A
    Ugeskr Laeger; 1996 Feb; 158(7):915-8. PubMed ID: 8638329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of the screening history of Alberta women with invasive cervical cancer.
    Stuart GC; McGregor SE; Duggan MA; Nation JG
    CMAJ; 1997 Sep; 157(5):513-9. PubMed ID: 9294389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytological screening history of patients with early invasive cervical cancer.
    Turner MJ; Keane DP; Flannelly GM; Lenehan PM; Murphy JF; Foley ME
    Ir Med J; 1990 Jun; 83(2):61-2. PubMed ID: 2202697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer screening: A Slovenian experience.
    Primic-Zakelj M; Repse-Fokter A
    Coll Antropol; 2007 Apr; 31 Suppl 2():23-6. PubMed ID: 17600934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The changing pattern of cervical cancer in Northern Ireland 1965-1989.
    Robertson JH; Woodend B
    Ulster Med J; 1992 Apr; 61(1):19-23. PubMed ID: 1621297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of the National Cervical Screening Programme on the presentation of cancer of the cervix in Canterbury.
    Simcock B; Sykes P; Laney M
    N Z Med J; 2001 Aug; 114(1138):378-80. PubMed ID: 11589435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in cancer of the cervix uteri in Sweden following cytological screening.
    Bergström R; Sparén P; Adami HO
    Br J Cancer; 1999 Sep; 81(1):159-66. PubMed ID: 10487628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.